Amron Arthur H 4
4 · NEPHROS INC · Filed Jan 9, 2023
Insider Transaction Report
Form 4
NEPHROS INCNEPH
AMRON ARTHUR H
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-05+7,080→ 7,080 totalExercise: $1.07Exp: 2033-01-05→ Common Stock (7,080 underlying) - Award
Common Stock
2023-01-05+27,613→ 27,613 total
Footnotes (2)
- [F1]On January 5, 2023, the Company granted 27,613 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company for 2022. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
- [F2]On January 5, 2023, the Company granted an option to purchase 7,080 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company for 2022. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,360 shares on each of 1/5/2023, 1/5/2024 and 1/5/2025.